糖尿病用再使用可能インスリンペンの世界市場:地域別展望・分析・市場規模・シェア・予測

DPI Researchが発行した調査報告書(DATA7100531)
◆英語タイトル:Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022
◆商品コード:DATA7100531
◆発行会社(リサーチ会社):DPI Research
◆発行日:2017年7月1日
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD1,100 ⇒換算¥117,700見積依頼/購入/質問フォーム
Site LicenseUSD1,600 ⇒換算¥171,200見積依頼/購入/質問フォーム
EnterprisewideUSD1,600 ⇒換算¥171,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDPI Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DPI Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.
Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices.

China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. United States is expected to become the third largest reusable insulin pen market by 2022.

The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints:

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows:

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed
6. Biocon Ltd.

【レポートの目次】

Table of Contents

1. Executive Summary

2. Reusable (Cartridge) Insulin Pen Market Environment & Trend (2011 – 2022)
2.1 Reusable (Cartridge) Insulin Pen Users
2.2 Reusable (Cartridge) Insulin Pen Market

3. Reusable (Cartridge) Insulin Pen Market Share Analysis (2011 – 2022)
3.1 Reusable (Cartridge) Insulin Pen Users Share
3.2 Reusable (Cartridge) Insulin Pen Market Share

4. Reusable (Cartridge) Insulin Pen Market Drivers and Barriers
4.1 Market Drivers
4.2 Market Barriers

5. Reusable (Cartridge) Insulin Pen Market in Top Ten Countries – Geographical Landscape
5.1 United States
5.1.1 Overall Diabetes Population
5.1.2 Insulin Users
5.1.3 Reusable (Cartridge) Insulin Pen Users
5.1.4 Reusable (Cartridge) Insulin Pen Market
5.2 Germany
5.2.1 Overall Diabetes Population
5.2.2 Insulin Users
5.2.3 Reusable (Cartridge) Insulin Pen Users
5.2.4 Reusable (Cartridge) Insulin Pen Market
5.3 France
5.3.1 Overall Diabetes Population
5.3.2 Insulin Users
5.3.3 Reusable (Cartridge) Insulin Pen Users
5.3.4 Reusable (Cartridge) Insulin Pen Market
5.4 Italy
5.4.1 Overall Diabetes Population
5.4.2 Insulin Users
5.4.3 Reusable (Cartridge) Insulin Pen Users
5.4.4 Reusable (Cartridge) Insulin Pen Market
5.5 Spain
5.5.1 Overall Diabetes Population
5.5.2 Insulin Users
5.5.3 Reusable (Cartridge) Insulin Pen Users
5.5.4 Reusable (Cartridge) Insulin Pen Market
5.6 United Kingdom
5.6.1 Overall Diabetes Population
5.6.2 Insulin Users
5.6.3 Reusable (Cartridge) Insulin Pen Users
5.6.4 Reusable (Cartridge) Insulin Pen Market
5.7 Japan
5.7.1 Overall Diabetes Population
5.7.2 Insulin Users
5.7.3 Reusable (Cartridge) Insulin Pen Users
5.7.4 Reusable (Cartridge) Insulin Pen Market
5.8 China
5.8.1 Overall Diabetes Population
5.8.2 Insulin Users
5.8.3 Reusable (Cartridge) Insulin Pen Users
5.8.4 Reusable (Cartridge) Insulin Pen Market
5.9 India
5.9.1 Overall Diabetes Population
5.9.2 Insulin Users
5.9.3 Reusable (Cartridge) Insulin Pen Users
5.9.4 Reusable (Cartridge) Insulin Pen Market
5.10 Brazil
5.10.1 Overall Diabetes Population
5.10.2 Insulin Users
5.10.3 Reusable (Cartridge) Insulin Pen Users
5.10.4 Reusable (Cartridge) Insulin Pen Market

6. Key Companies Analysis
6.1 Novo Nordisk
6.1.1 Business Overview
6.1.2 Reusable Insulin Pen – Products Portfolio
6.1.3 Insulin Pen – Latest Development & Trends
6.2 Eli Lilly
6.2.1 Business Overview
6.2.2 Insulin Pen – Products Portfolio
6.2.3 Insulin Pen – Latest Development & Trends
6.3 Sanofi
6.3.1 Business Overview
6.3.2 Insulin Pen – Products Portfolio
6.4 Owen Mumford
6.4.1 Business Overview
6.4.2 Insulin Pen – Products Portfolio
6.5 Ypsomed
6.5.1 Business Overview
6.5.2 Insulin Pen – Products Portfolio
6.5.3 Insulin Pen – Latest Development & Trends
6.6 Biocon Ltd.
6.6.1 Business Overview
6.6.2 Insulin Pen – Products Portfolio

List of Tables:

Table 3 1: 10 Countries – Reusable Insulin Pen Users Share (Percent), 2011 – 2016
Table 3 2: 10 Countries – Forecast for Reusable Insulin Pen Users Share (Percent), 2017 – 2022
Table 3 3: 10 Countries – Reusable Insulin Pen Market Share (Percent), 2011 – 2016
Table 3 4: 10 Countries – Forecast for Reusable Insulin Pen Market Share (Percent), 2017 – 2022
Table 4 2: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040



List of Figures

Figure 2 1: 10 Countries – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 2 2: 10 Countries – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 2 3: 10 Countries – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 2 4: 10 Countries – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 3: United States – Insulin Users(Thousand),2011 – 2016
Figure 5 4: United States – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 5: United States – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 6: United States – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 7: United States – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 8: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 9: Germany – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 10: Germany – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 11: Germany – Insulin Users(Thousand),2011 – 2016
Figure 5 12: Germany – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 13: Germany – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 14: Germany – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 15: Germany – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 16: Germany – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 17: France – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 18: France – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 19: France – Insulin Users(Thousand),2011 – 2016
Figure 5 20: France – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 21: France – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 22: France – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 23: France – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 24: France – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 25: Italy – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 26: Italy – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 27: Italy – Insulin Users(Thousand),2011 – 2016
Figure 5 28: Italy – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 29: Italy – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 30: Italy – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 31: Italy – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 32: Italy – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 33: Spain – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 34: Spain – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 35: Spain – Insulin Users(Thousand),2011 – 2016
Figure 5 36: Spain – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 37: Spain – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 38: Spain – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 39: Spain – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 40: Spain – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 41: United Kingdom – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 42: United Kingdom – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 43: United Kingdom – Insulin Users(Thousand),2011 – 2016
Figure 5 44: United Kingdom – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 45: United Kingdom – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 46: United Kingdom – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 47: United Kingdom – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 48: United Kingdom – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 49: Japan – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 50: Japan – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 51: Japan – Insulin Users(Thousand),2011 – 2016
Figure 5 52: Japan – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 53: Japan – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 54: Japan – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 55: Japan – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 56: Japan – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 57: China – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 58: China – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 59: China – Insulin Users(Thousand),2011 – 2016
Figure 5 60: China – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 61: China – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 62: China – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 63: China – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 64: China – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 65: India – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 66: India – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 67: India – Insulin Users(Thousand),2011 – 2016
Figure 5 68: India – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 69: India – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 70: India – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 71: India – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 72: India – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 5 73: Brazil – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 5 74: Brazil – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 5 75: Brazil – Insulin Users(Thousand),2011 – 2016
Figure 5 76: Brazil – Forecast for Insulin Users(Thousand),2017 – 2022
Figure 5 77: Brazil – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 5 78: Brazil – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 5 79: Brazil – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 5 80: Brazil – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病用再使用可能インスリンペンの世界市場:地域別展望・分析・市場規模・シェア・予測(Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆